Accordingly, Wu et al. have demonstrated that LY2801653 (a MET inhibitor) significantly inhibits both primary tumor growth and metastasis to the lymph nodes and chest wall in H441 orthotopic models [39]. This evidence concerns the gene MET and neoplasm.